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Available online 27 December 2014Abstract The intestinal epithelium is a particularly attractive biological adult model to study epigenetic mechanisms driving
adult stem cell renewal and cell differentiation. Since epigenetic modifications are dynamic, we have developed an original ex
vivo approach to study the expression and epigenetic profiles of key genes associated with either intestinal cell pluripotency or
differentiation by isolating cryosections of the intestinal crypt-villus axis. Gene expression, DNA methylation and histone
modifications were studied by qRT-PCR, methylation-specific PCR and micro-chromatin immunoprecipitation, respectively.
Using this approach, it was possible to identify segment-specific methylation and chromatin profiles. We show that (i) expression of
intestinal stem cell markers (Lgr5, Ascl2) exclusively in the crypt is associated with active histone marks, (ii) promoters of all
pluripotency genes studied and transcription factors involved in intestinal cell fate (Cdx2) harbour a bivalent chromatin pattern in
the crypts and (iii) expression of differentiation markers (Muc2, Sox9) along the crypt-villus axis is associated with DNA
methylation. Hence, using an original model of cryosectioning along the crypt-villus axis that allows in situ detection of dynamic
epigeneticmodifications, we demonstrate that regulation of pluripotency and differentiationmarkers in healthy intestinal mucosa
involves different and specific epigenetic mechanisms.
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106 A. Vincent et al.IntroductionCell differentiation in adults involves flexible but precise
control of the expression of genes specific for each cell
fate or pluripotency. Crucial changes in their expression are
most likely controlled by specific epigenetic rearrangements
(Vincent & Van Seuningen, 2009). Extensive studies conducted
to characterise embryonic stem cells (ESC) at the epigenetic
level have shown that ESC harbour a permissive chromatin with
hypomethylation of their genome compared to differentiated
cells (Bibikova et al., 2006) and bivalent histone marks where
large regions containing trimethylated K27H3 (gene silencing)
colocalise with smaller regions containing methylated K4H3
(gene activation) (Bernstein et al., 2006). This allows rapid
transcriptional activation of genes specific for a cell fate. One
can hypothesise that the plasticity of adult SC involves similar
epigenetic mechanisms. However, only a few studies mostly
conducted in vitro have addressed this concept.
The intestinal epithelium is a particularly attractive
biological adult model to study epigenetic mechanisms driving
differentiation in vivo. In the intestinal epithelium, two
populations of SC have already been described and isolated
(Lgr5+ and Bmi1+ cells; Barker et al., 2007; Sangiorgi &
Capecchi, 2008). Epithelial cell turnover in the intestine is
particularly fast and occurs from a well-identified structure,
the so-called niche, which provides an optimal microenviron-
ment for SC ensured by epithelial and mesenchymal cells and
extracellular substrates (Scoville et al., 2008). Therefore, the
intestinal crypt has been defined as a perfect prototype SC
compartment (Clevers, 2013a) and is a model of choice to
study epigenetic mechanisms involved in adult epithelial cell
differentiation. In a recent study based on cell sorting of
labelled SC, fifty differentially methylated regions have been
identified as driving intestinal SC (ISC) differentiation (Kaaij et
al., 2013). Similarly, numerous studies aiming at deciphering
cell differentiation mechanisms have been performed either
after cell sorting, following in vitro culture of SC forced to
engage in specific lineages (Pennarossa et al., 2013), or after
fractionation methods used to isolate enriched cell subpopu-
lations (Barnard et al., 1989). However, epigenetic profiles
are very dynamic and can be profoundly modified during cell
culture (Allegrucci et al., 2007) or through cell sorting.
Moreover, the lack of reliable tools to isolate ISC forced
investigators to avoid the use of specific antibodies by using
genetically modified mouse models, where ISC carry fluores-
cent labels (Wang et al., 2013; Ramalingam et al., 2012).
These models were very informative since they already
pointed out some epigenetic modifications that are crucial
(Sheaffer et al., 2014) or even dispensable (Ho et al., 2013) for
intestinal epithelial cell differentiation. However, they may
not reflect the progressive epigenetic changes necessary
for differentiation programming in vivo, especially in humans
where these labelling approaches cannot be applied.
In order to circumvent these pitfalls, we have devel-
oped an original ex vivo method allowing precise cryo-
sectioning of the whole intestinal crypt-villus (CV) axis.
This method allowed us (i) to establish the expression and
epigenetic profiles of key genes associated with either
intestinal cell pluripotency or differentiation and (ii) to
show that specific epigenetic programs are engaged in
these processes.Material and methods
Sample collection and cryosectioning the CV axis
All procedures were in accordance with the guideline of
animal care committee (Comité Ethique Expérimentation
Animale Nord Pas-de-Calais, CEEA75). The distal small
intestine from wild-type C57BL/6 mice was collected,
separated from mesenteric residues, rinsed in 1×
phosphate-buffered saline (PBS), sectioned into pieces of
1 cm in length and opened longitudinally with special
intestine scissors (FST 14080-11) to avoid tearing. These
small intestine fragments were uniformly flattened with the
villi pointing upwards in a 15 × 15 × 5mm Tissue-Tek®
cryomold® mold and covered with tissue freezing medium
(O.C.T.) (Fig. 1A) before immediate snap-freezing in
isopentane cooled at −80 °C (SnapFrost® 80, Alphelys) to
avoid cell and nucleus wall damages upon freezing. Frozen
tissue blocks were placed on the tissue holder of a cryostat
at −20 °C with the villi pointed downwards. The specimen
head was oriented in order to section the tissue transversely
at 10 μm thickness from the muscular layer through the
mucosa until the top of the villi. Four consecutive sections
were used as one sample and referred to as one “layer” of
the CV axis. Each of the 13 layers of one tissue block was
then used either for RNA, DNA extraction or for micro-
Chromatin ImmunoPrecipitation assays (μChIP). Between
each 40 μm-layer, one 5 μm-section was mounted and
stained with standard hematoxylin and eosin (HE) in order
to check for crypt and villus morphology, right sectioning
progression along the CV axis (muscular layer, crypt
bottoms, crypts, CV junctions, villi and top of the villi) and
anatomic consistency between the layers of independent
tissue blocks (Fig. 1C).RNA isolation
Total RNA was extracted from each of the layers of
one tissue block using the NucleoSpin RNA XS Kit
(Macherey-Nagel) following the manufacturer's protocol.
Total RNA yields varied in average from approximately
140 ng in samples corresponding to bottom and top layers,
where cells are sparse, to 5.9 μg in samples corresponding
to intermediate layers. The layers of at least three tissue
blocks collected from different mice were independently
used for expression profile studies along the CV axis.Quantitative reverse transcription polymerase
chain reaction (qRT-PCR)
Total RNA (140–500 ng) were reverse transcribed using
random hexamers (1 μl) and recombinant RT Moloney Murine
Leukemia Virus (M-MLV) (Promega). cDNAs were quantified
using the SsoFast EvaGreen supermix (Bio-Rad). qRT-PCR
was performed on a Bio-Rad CFX96 real-time thermocycler.
Primer sequences are listed in Table S1. Fold changes were
calculated according to the 2−ΔΔCt method where GUSB, and
TBP housekeeping genes were used for normalisation and the
sample corresponding to the bottom of the crypt was used as
a reference.
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Figure 1 Cryosectioning the CV axis. (A) Photographs representing the flattened intestinal mucosa in a cryomold before and after
snap-freezing. (B) Schematic representation of the intestinal mucosa delineated into crypts and villi. Numbers represent each layer
or sample, constituted of four consecutive 10 μm cryosections. Discontinued line represents the 5 μm-cryosections used for
examination by light microscopy of the morphology and progression along the CV axis on a slide stained with standard HE (C).
Magnification ×100. The scale bar indicates 200 μm.
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Genomic DNA was extracted from each of the layers of
one tissue block using the NucleoSpin DNA XS Kit
(Macherey-Nagel) following the manufacturer's protocol.
Total DNA yields varied in average from approximately
880 ng in samples corresponding to bottom and top layers
where cells are sparse to 6.9 μg in samples corresponding
to intermediate layers. The layers of at least three tissueblocks collected from different mice were independently
used for DNA methylation profile studies along the CV axis.Methylation-specific PCR (MSP)
The methylation status of target gene promoters was deter-
mined by MSP as previously described (Vincent et al., 2011)
using specific primers for methylated and unmethylated DNA
108 A. Vincent et al.(listed in Table S2). DNA treated with SssI methylase (New
England Biochemicals) and whole-genome amplified DNA
(REPLI-g Mini Kit, Qiagen) were used as controls for
methylated and unmethylated DNA, respectively. Samples
harbouring amplifications with both methylated and
unmethylated specific primers were considered partially
methylated.Micro-chromatin immunoprecipitation assaysFresh pieces of small intestine (~1 cm2) were fixed in
formaldehyde 1% (v/v) in 1× PBS containing complete
protease inhibitor cocktail tablets (Roche) for 10 min at
room temperature. Fixation was stopped with 0.125 M
glycine, and the tissues were rinsed with 1× PBS containing
complete protease inhibitor cocktail tablets (Roche)
before snap-freezing and cryosectioning as described
above.
Each selected 40 μm layer of the CV axis of one tissue
block was incubated for 10 min on ice in 100 μl of the tL1
lysis buffer from the True μChIP Kit (Diagenode) contain-
ing a provided protease inhibitor cocktail. Three volumes
of HBSS were then added before chromatin shearing using
the Bioruptor® (24 cycles, 30 s on, 30 s off, Diagenode).
Sheared chromatin was separated from cell debris
through centrifugation (14 000 ×g, 10 min, 4 °C), and
optimal size was monitored in a 1.5% (v/v) agarose gel run
in 1× sodium borate buffer in the presence of ethidium
bromide.
Sheared chromatin was diluted v/v in ChIP Buffer tC1
(True μChIP Kit) according to Diagenode's instructions and
divided into four equal aliquots. Two were used for immuno-
precipitation at 4 °C on a rotating wheel for 16 h with
specific antibodies (0.25 μg for 0.1 A260nm) against either
H3K9 (pAb-056-050, Diagenode), H3K27 (#39155, Active
Motif) or H3K4 (True μChIP Kit, Diagenode) trimethylation
were used. A third aliquot was used for immunoprecipitation
with the same amount of rabbit IgGs (Millipore) as a negative
enrichment control. The fourth aliquot was set aside as the
input sample and kept overnight at −20 °C until purifica-
tion. Prewashed magnetic beads (True μChIP Kit, Diagenode)
were used to capture the immunoprecipitated chromatin
and washed with provided buffers according to the
manufacturer's instructions. After the last wash with tW4
buffer, immunoprecipitated chromatin was eluted from the
True μChIP beads using 120 μl of freshly prepared elution
buffer from the I-Pure Kit (Diagenode) and incubated at
65 °C overnight for reverse cross-linking along with the input
sample. Immunoprecipitated and input samples were then
purified according to the manufacturer's instructions and
eluted with 25 μl of provided elution buffer C (I-Pure Kit,
Diagenode). The presence of histone marks on target gene
promoters was directly assessed using 2 μl of the sample into
a 20 μl qPCR reaction using the SsoFast EvaGreen supermix
(Bio-Rad) on a Bio-Rad CFX96 real-time thermocycler.
Primers are listed in Table S3. Fold enrichments for each
layer were calculated according to the 2−ΔΔCt method where
the input sample was used for normalisation and the sample
immunoprecipitated with the control IgGs was used as the
reference.Results and discussion
Cryosections of the CV axis reflect the gradients of
expression of SC and differentiation markersHE staining of the different segments following cryo-
sectioning confirmed the morphological evolution and cell
distribution along the CV axis (Fig. 1B). Expression of SC
markers Lgr5 and Bmi1 was found mainly at the bottom of
the crypt and decreased progressively toward the CV
junction to become virtually absent from the villi (Fig. 2A).
Putative SC marker Ascl2 showed a comparable profile with
a small increase of expression at the CV junction compared
to the bottom of the crypt indicating that Ascl2 may be a
progenitor marker rather than a true SC marker. These
results confirm their expression profile previously described
(Itzkovitz et al., 2012).
As expected, Sox9, which encodes a transcription factor
playing roles in intestinal epithelial cell fate including
terminal differentiation of the secretory lineage and SC
maintenance (Mori-Akiyama et al., 2007), was over-
expressed in the crypts compared to the villi (Fig. 3A). The
expression study of Cdx2 which encodes a transcription
factor involved in epithelial cell terminal differentiation
(Chawengsaksophak et al., 1997) (Fig. 3A) and one of its
transcriptional targets (Benoit et al., 2010), Sis encoding the
absorptive lineage marker sucrase isomaltase (Fig. S2),
showed that they were mostly found in the villi and the top
of the villi while they were largely underrepresented in the
crypts until the CV junction. Similarly, we found that Casp3,
which encodes a caspase involved in the shedding of
differentiated cells by apoptosis at the top of the villi
(Grossmann et al., 2002), was gradually expressed from the
bottom of the crypt to the top of the villi (Fig. S2).
Muc2, which encodes a goblet cell marker and the major
component of intestinal mucus (Tytgat et al., 1994), was
inconstantly expressed along the CV axis (Fig. 3A). This is
concordant with the fact that goblet cells are disseminated
along the CV axis and only represent about 10% of the
intestinal epithelium. Interestingly, Muc2 was also highly
expressed at the bottom of the crypts, where goblet cells
are not fully differentiated. This is in accordance with our
previous findings showing that Muc2 mRNAs are found at the
bottom of the crypts early during mouse and human
development, before terminal differentiation of goblet
cells (Buisine et al., 2000).
Finally, we found that while ChgA, which encodes the
neuroendocrine cell marker Chromogranin A, was uniformly
expressed along the CV axis, Defa24, which encodes the
Paneth cell marker Defensin alpha 24, was 7-fold over-
expressed in the crypt segments compared to the strict
bottom of the crypt and was decreased in the layers
corresponding to the villi (Fig. S2). These data are con-
cordant with the distribution of neuroendocrine cells and
Paneth cells, which are found either equally distributed
along the CV axis or exclusively in the crypts, respectively.
Altogether these results validate our cryosectioning
method since we confirmed the previously described
gradients of expression of genes involved either in stemness
and pluripotency or in absorptive and secretory lineages of
the mouse intestinal mucosa.
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Figure 2 Transcriptional and epigenetic profile of SC markers along the CV axis. (A) Expression profile in each layer of the CV axis of
one tissue block was studied by qRT-PCR. Graphs represent relative expression normalised with the housekeeping genes GUSB and
TBP. The sample corresponding to the bottom of the crypt was used as a reference and fold changes were calculated according to the
2−ΔΔCt method. Error bars represent technical replicates of each layer of one tissue block. (B) Schematic representation of the
intestinal mucosa delineated into the 13 40 μm-layers of the CV axis that were used either for mRNA expression, MSP or ChIP analysis.
(C) DNA methylation profile in each layer of the CV axis at promoters of SC markers was studied by MSP. White boxes indicate the
absence of DNA methylation in a layer (rows) at the CpG island of a specific gene (column). (D) Fold enrichment (×1000) of active
histone mark H3K4me3 (green bars), and repressive histone marks H3K9me3 (light red bars) and H3K27me3 (dark red bars) in the
promoters of pluripotency genes by μChIP. Input samples were used for normalisation, and control IgGs were used as a reference for
fold-enrichment calculation using the 2−ΔΔCt method.
109Stem Cell Research — Methods and ReagentsExpression of SC markers and transcription factors
along the CV axis is associated with a specific
histone modification pattern
We chose to study pluripotency genes (Lgr5, Bmi1 and Ascl2)
and genes encoding transcription factors (Cdx2) in which we
had found CpG islands in the 3 kb region upstream their
transcription or translation start site (Fig. S1) either with
MethPrimer (Li & Dahiya, 2002) or in the UCSC Genome
Browser (Kent et al., 2002). For μChIP, we chose three
histone modifications known to be involved during develop-
ment and embryonic SC differentiation in mammals:H3K9me3 and H3K27me3 involved in the silencing of genes
that are irrelevant to the lineage in which the cells are
engaged (Loh et al., 2007; Shen et al., 2008) and H3K4me3
which is essential for the expression of specific differenti-
ation markers.
DNA methylation was absent from Lgr5, Bmi1 and Ascl2
promoters regardless of the position in the CV axis
(Fig. 2C). The active histone mark H3K4me3 was enriched
at Lgr5 promoter exclusively in the crypts (Fig. 2D),
where Lgr5 is expressed (Fig. 2A). The highest enrichment
for the two repressive marks H3K9me3 and H3K27me3
were found at the CV junction and in the villi (Fig. 2D),
B1
2
3
4
5
6
7
8
9
10
11
12
13
CA
D
Fold expression (/TBP+GUSB)
Cdx2 Muc2
R
el
a
tiv
e
 fo
ld
 
e
n
ric
hm
en
t
Figure 3 Transcriptional and epigenetic profile of transcription factors and differentiation markers along the CV axis. (A)
Expression profile in each layer of the CV axis of one tissue block was studied by qRT-PCR. Graphs represent relative expression
normalised with the housekeeping genes GUSB and TBP. The sample corresponding to the bottom of the crypt was used as a reference
and fold changes were calculated according to the 2−ΔΔCt method. (B) Schematic representation of the intestinal mucosa delineated
into the 13 40 μm-layers of the CV axis that were used either for mRNA expression, MSP or ChIP analysis. (C) DNA methylation profile
in each layer of the CV axis at promoters of differentiation markers was studied by MSP. White boxes indicate the absence of DNA
methylation in a layer (rows) at the CpG island of a specific gene (column). Grey boxes indicate partial methylation. (D) Fold
enrichment (×1000) of active histone mark H3K4me3 (green bars), and repressive histone marks H3K9me3 (light red bars) and
H3K27me3 (dark red bars) in the promoters of differentiation markers by μChIP. Input samples were used for normalisation and
control IgGs were used as a reference for fold-enrichment calculation using the 2−ΔΔCt method.
110 A. Vincent et al.where Lgr5 shows low or no expression (Fig. 2A). Hence,
there is a good correlation between Lgr5 expression
profile and the presence of active histone marks in the
crypt. Interestingly, the promoters of Lgr5, Bmi1 and
Ascl2 harboured chromatin bivalency (presence of both
active and repressive histone marks) in the higher crypts
(Lgr5, Bmi1), at the CV junction and in the lower villi
(Bmi1) or in the entire crypts (Ascl2). Lgr5 and Ascl2
promoters were enriched exclusively with repressive
marks in the villi. At the top of the villi, the three
promoters were enriched exclusively with H3K9me3 and
H3K27me3 (Fig. 2D).Similarly, Cdx2 CpG island was not methylated regardless
of the depth in the CV axis. It was enriched with both
H3K4me3 and H3K27me3 in the higher crypts and at the CV
junction where progenitor cells are located (Fig. 3D). At the
bottom of the crypt, where Cdx2-expressing Paneth cells are
located, we were only able to observe an enrichment of
H3K4me3. Similarly, in the villi, where Cdx2 transcripts were
mostly found (Fig. 3A), Cdx2 CpG island was exclusively
associated with H3K4me3. It has already been suggested
that Suz12, a member of the PcG complex overexpressed in
the crypts where it catalyses H3K27me3, may inhibit cell
differentiation by silencing Cdx2 expression (Benoit et al.,
111Stem Cell Research — Methods and Reagents2012). Here we confirm the presence of this repressive
histone mark exclusively in the progenitor cell compartment
and therefore further endorse the crucial role of this
transcription factor in the regulation of terminal epithelial
differentiation in the intestine. Moreover, Cdx2 contributes
to the establishment and maintenance of the active mark
H3K4me3 (Verzi et al., 2013), pointing out the interconnec-
tions between epigenetic regulation and transcription
factors upon differentiation.
Bivalency has been first described in ESC at “poised”
genes, ready to respond to differentiation signals (Bernstein
et al., 2006). Interestingly, the ISC marker Bmi1 has been
shown to play a critical role in this mechanism in adult SC
and progenitors (Oguro et al., 2010). This bivalency could be
due to different allelic states (Tollervey & Lunyak, 2012) or
cell heterogeneity as it may be the case for Muc2 promoter
where mixed enterocytes and goblet cells induce partial
methylation (Gratchev et al., 2001). However, the fact that
not all promoters at the bottom of the crypt harbour this
bivalency suggests that there is a real progression in
epigenetic profiles along the CV axis and that SC and
differentiated cells located at the bottom of the crypt may
share some epigenetic features. This will have to be further
validated using single cell approaches such as ISH-PLA
(Gomez et al., 2013). This is interesting since it has been
hypothesised that Paneth cells would derive from specific
progenitors that are able to revert back into Lgr5+ SC while
the rest of the intestinal epithelial cells derive from other
progenitors after multiple cycling (Clevers, 2013b). There-
fore, other differentiated cells may be epigenetically more
distant from the SC of origin than Paneth cells. This points
out the relevance of studying epigenetic profiles as a
progression along the CV axis rather than in sorted cells
where they are separated essentially on the basis of their
terminal phenotype. This confirms the relevance of our
method in addition to other approaches when it comes to
genome-wide studies.Sox9 promoter is associated with partial DNA
demethylation only in the villiWe then studied the DNA methylation profile of the CpG
island found in the promoter of Sox9, which encodes a
transcription factor involved both in SC maintenance and
establishment of the secretory lineage (Blache et al., 2004).
Interestingly, Sox9 promoter was totally unmethylated in
the crypts where it is the most highly expressed (Fig. 3A,
layer 3, and Ramalingam et al., 2012) but was found partially
methylated in some cryosections corresponding to the villi
and at the top of the villi (Fig. 3C). Hence, DNA methylation
may be responsible for the absence of Sox9 expression only
in terminally differentiated enterocytes, which represent
90% of the villus epithelial cell contingency. Since Sox9 has
been recently described as a marker of the fifth type of
intestinal epithelial cells, the Tuft cells (Gerbe et al., 2011),
the absence of methylation in some layers or the fact that
we were able to only show partial methylation in the villi
may be due to the presence of these rare Sox9-expressing
cells unequally distributed all along the villi. SOX9 promoter
has been described as hypermethylated in several cancertypes but, to our knowledge, its methylation profile has not
been studied in normal intestinal cells so far.Expression of Muc2 along the CV axis is associated
both with a specific histone code and DNA
methylation profile
We found that the promoter of Muc2, encoding the main
goblet cell marker, was partially methylated in almost all
layers along the CV axis (Fig. 3C). Partial methylation of
Muc2 promoter has already been reported in human colon
where the percentage of microdissected goblet cells has
been shown to interfere with the percentage of MUC2 CpG
island methylation (Gratchev et al., 2001). Interestingly, no
methylation was observed at the bottom of the crypt, where
Muc2 transcripts were found the most abundant (Fig. 3A).
Following the same epigenetic pattern along the CV axis, low
enrichment was found for repressive histone marks at the
bottom of the crypts while Muc2 promoter was enriched with
H3K27me3 and/or H3K9me3 from the crypt junction to the
top of the villi, indicating that most of the differentiated
cells present in the villi (i.e. enterocytes) harbour a silenced
Muc2 promoter characterised by a high percentage of
methylation and a repressive histone code. Concordant
with the high expression of Muc2 in the crypts, the highest
enrichment for H3K4me3 was found in this compartment. We
and others have previously described epigenetic regulation
of Muc2 in several cancer types. This suggests that the same
epigenetic mechanisms are involved in Muc2 (and Sox9)
regulation in normal and cancer cells. On the contrary, DNA
hyper- or hypomethylation of Cdx2 and SC markers has not
been described in normal tissues and seems to be
cancer-specific (Kawai et al., 2005; Kwon et al., 2013). It
has been suggested that aberrant DNA methylation observed
in cancer may be associated with a bivalency state observed
in SC (Rodriguez et al., 2008). Further investigation asso-
ciating our cryosectioning model with epigenome-wide
studies will be of great interest to answer this yet unsolved
question.
Altogether, our data indicate that terminal differentia-
tion markers are specifically regulated by DNA methylation
and histone modifications while most of the other genes are
regulated by histone modifications. Further studies, includ-
ing the analysis of methylation profiles of differentiation
markers that do not harbour a CpG island, will be necessary
to confirm this hypothesis in our model since these regions
have been shown to play an important role in cell
differentiation (Miranda & Jones, 2007). Nonetheless, our
results are in total accordance with other epigenome-wide
studies showing that healthy adult cells acquire only a few
changes in DNA methylation profiles, affecting only a small
percentage of tissue-specific genes (around 6%), upon
differentiation (Berdasco & Esteller, 2011). This is especially
true in healthy intestinal tissues where bisulfite sequencing
studies have shown that DNA methylation profiles are
particularly stable (Kaaij et al., 2013).
Interestingly, we found a very good correlation between
the expression profile of studied genes and their histone
modification pattern, hence validating our hypothesis of
epigenetic mechanisms playing crucial roles in the estab-
lishment of intestinal cell differentiation (Vincent & Van
112 A. Vincent et al.Seuningen, 2009) and validating our strategy along the CV
axis.
Conclusion
Both our expression data, which are concordant with
previously found gradient profiles along the CV axis, and
our epigenetic profile studies, which are in accordance with
current knowledge about epigenetic mechanisms in normal
differentiating cells, validate our method. Our results,
obtained with semi-quantitative methods, such as MSP,
allow us to consider using more sensitive and quantitative
techniques to decipher epigenome-wide regulation of
intestinal and colonic cell differentiation. Moreover, unlike
cell sorting assays, our direct ex vivo method on fixed
tissues, which does not involve a dissociation step, does not
alter epigenetic profiles and is easier to set up. It will allow
us to section out, capture and map gradual epigenetic
progressions along the CV axis. This method is also a great
additional asset to assess whether there is a rapid switch
in epigenetic profiles in transit amplifying progenitor cells
as they migrate and engage into a particular cell fate
under the influence of neighbouring cells (Kim et al.,
2014). Finally, as carcinogenesis is described as a dedif-
ferentiation (reprogramming of differentiated cells) or a
dysdifferentiation (aberrant programming of SC) process
(Vincent & Van Seuningen, 2012), unravelling the epige-
netic mechanisms accompanying normal cell differentia-
tion using this method will be particularly useful to
understand the aberrant epigenetic alterations universally
observed in tumours.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.12.002.
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